Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,521,996
-
Share change
-
+116,734
-
Total reported value
-
$3,456,000
-
Price per share
-
$2.27
-
Number of holders
-
15
-
Value change
-
+$253,272
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of ONCONOVA THERAPEUTICS INC - COM NEW (ONTX) as of Q4 2016
As of 31 Dec 2016,
ONCONOVA THERAPEUTICS INC - COM NEW (ONTX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,521,996 shares.
The largest 10 holders included
TYNDALL CAPITAL PARTNERS L P, SABBY MANAGEMENT, LLC, Boxer Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Weiss Multi-Strategy Advisers LLC, CITADEL ADVISORS LLC, KCG HOLDINGS, INC., Acrospire Investment Management LLC, and UBS Group AG.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.